Indivior’s anti-opioid addiction drug struggles against generic competitors
In the three months to 30 September, total net revenue decreased 19% to US$199mln
Company
LON: INDV
The world leader in addiction treatment with 20 years of experience and a unique, patient-focused approach.We didn’t become the world leader in addiction treatment overnight. Our endeavor started small, with one singular focus – to intimately understand the journey of individuals suffering with addiction. People with addiction are often stereotyped and discounted, creating an environment where many are under-diagnosed, undertreated and under-supported. They’re often unaware of their treatment options, have limited access to treatment, or simply don’t seek it out because they’re afraid of being stigmatized.
42 stories · page 3 of 3
In the three months to 30 September, total net revenue decreased 19% to US$199mln
The company expects 2019 group net revenue to be up to US$790mln, compared to previous forecasts of up to US$720mln